Lamy Patrick (CIK 0001961273)

Latest company ownership

AKRO - Akero Therapeutics, Inc.

Role: Senior VP, Commercial Strategy

Shares held

29,891

Last filed at

Jul 3, 2025

Confidence Score

44.6

2025Q4

Confidence Score History

2024Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jul 1, 2025	Jul 3, 2025	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	32.5	-2,000	-6.27%	✓	$105.8K
Jun 20, 2025	Jun 20, 2025	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	46.3	-875	-2.69%	✗	$47.8K
Jun 16, 2025	Jun 20, 2025	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	32.5	-2,000	-5.78%	✓	$108.3K
Jun 10, 2025	Jun 12, 2025	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	46.3	-919	-2.74%	✗	$49.6K
Jun 2, 2025	Jun 4, 2025	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	25.0	-4,000	-10.67%	✓	$201.3K
May 22, 2025	May 23, 2025	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	25.0	-4,000	-10.67%	✓	$200K
May 7, 2025	May 9, 2025	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	17.5	-8,000	-19.28%	✓	$340K
Mar 3, 2025	Mar 5, 2025	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	45.0	-1,000	-2.90%	✓	$48.1K
Dec 31, 2024	Jan 29, 2025	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	30.0	-4,766	-6.55%	✓	$285.2K
Dec 16, 2024	Dec 18, 2024	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	91.3	+16,400	91.84%	✓	$29.1K
Dec 10, 2024	Dec 12, 2024	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	46.3	-925	-4.92%	✗	$28.5K
Jun 11, 2024	Jun 13, 2024	Akero Therapeutics, Inc.	Senior VP, Commercial Strategy	Sell	46.3	-569	-2.97%	✗	$12.9K